Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol

Clinical Trial Description

RDW values have been found to be an independent predictor of the prognosis among patients with heart diseases, stroke,community-acquired pneumonia (CAP), pulmonary embolism, chronic obstructive pulmonary disease (COPD), septic shock, and acute pancreatitis. ;

Study Design

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06173817` - The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients	Phase 2/Phase 3
	Completed	`NCT04877067` - Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation	Phase 3

See also

Status

Clinical Trial

Phase

Recruiting

NCT06173817 - The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients

Phase 2/Phase 3

Completed

NCT04877067 - Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04064801
Study type	Observational
Source	Adana Numune Training and Research Hospital
Contact
Status	Completed
Phase
Start date	March 15, 2020
Completion date	August 30, 2020

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms